Tulane Releases

Stephen Griffin's Law of Democracy class has given Tulane School of Law students an up-close look at the issues surrounding the 2020 presidential election.

Tulane University School of Medicine will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III clinical research study of a new COVID-19 vaccine.

Amanda Garcia, the director for Tulane University’s School of Professional Advancement Digital Design program, has been named “Educator of the Year” by The Advertising Club of New Orleans for her work in fostering the growth of the next generation of advertising professionals.

With little over a month remaining in an on-ground, in-person semester that many believed would never happen, Tulane University has announced its plans for the spring 2021 semester. 

Tulane professor and author Walter Isaacson knew that the world-changing work of biochemist Jennifer A. Doudna was on par with the subjects of his previous books that include biographies of Leonado DaVinci and Steve Jobs. The Royal Swedish Academy of Sciences underscored this sentiment in a big way last week by awarding the 2020 Nobel Prize in chemistry to Doudna, the central subject of Isaacson’s new book. Doudna shared the prestigious honor with her colleague, Emmanuelle Charpentier, for the co-development of CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine.

A Tulane student got sick of tossing beverage bottles in the trash, so he started Louisiana's first glass recycling facility in New Orleans. Now he and his team are taking it to the next level.

A Tulane researcher will use a grant from the U.S. Department of Agriculture to study the impact of noxious weed invasion on livestock, food production and supermarket prices.

The U.S. Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2.5 million grant to Tulane University School of Public Health and Tropical Medicine to work with community partners determine if a value-based benefit approach using zero-cost copayments on drugs can improve medication adherence and outcomes for diabetes patients.